Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
Clinical trial NCT03674567 · COMPLETED
Trial details
- NCT number
- NCT03674567
- Sponsor
- RAPT Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2024-12-31
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.